# Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

> **NCT00537719** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 34 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GSK716155
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00537719
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-07
- **Primary completion:** 2008-04-04
- **Final completion:** 2008-04-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537719, "Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00537719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*